Transplant Area and Tissue Bank, Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad (INTO), Av. Brasil, 500, Rio de Janeiro, RJ, 0940-070, Brazil.
Director of the Institute of Medical Education, Campus Vista Carioca University of Estácio de Sá, Rio de Janeiro, RJ, Brazil.
Cell Tissue Bank. 2024 Jun;25(2):625-632. doi: 10.1007/s10561-024-10125-4. Epub 2024 Feb 17.
Bone allografts are clinically used in a variety of surgical procedures, and tissue banks are responsible for harvesting, processing, quality testing, storing, and delivering these materials for transplantation. In tissue banks, the bone is processed for the removal of all organic content, remaining only the tissue structure (scaffold). However, several studies have shown that even after using different processing methods, viable cells, functional proteins, and DNA may still persist in the tissue, which constitute the main causes of graft rejection. Therefore, the objective of this study was to establish techniques and biological parameters for quality validation of allografts. To this end, we propose the use of 3 combined methods such as microscopy, histology, and molecular biology techniques to evaluate the quality of allografts harvested and processed by the Brazilian National Institute of Traumatology and Orthopedics (INTO) tissue bank according to the donation criteria of the Brazilian National Health Surveillance Agency and the Brazilian National Transplant System. Bone fragments from different processing stages showed no viable cells on histology, an intact extracellular matrix on scanning electron microscopy, and gradual reduction in DNA amount. Different techniques were used to demonstrate the quality of allografts produced by the INTO tissue bank and to establish biological parameters for ensuring the safety and quality of these products. Future studies need to be undertaken to assess and validate the efficacy of the decellularization process in larger bone grafts with diverse architectural configurations.
同种异体骨被广泛应用于各种外科手术中,组织库负责采集、处理、质量检测、储存和运送这些材料用于移植。在组织库中,骨被加工以去除所有有机物质,仅留下组织结构(支架)。然而,多项研究表明,即使使用不同的处理方法,活细胞、功能蛋白和 DNA 仍可能残留在组织中,这是导致移植物排斥的主要原因。因此,本研究旨在建立同种异体骨质量验证的技术和生物学参数。为此,我们提出使用显微镜、组织学和分子生物学技术相结合的 3 种方法,根据巴西国家卫生监督局和巴西国家移植系统的捐赠标准,评估巴西国家创伤和矫形研究所(INTO)组织库采集和处理的同种异体骨的质量。不同处理阶段的骨碎片在组织学上未显示有活细胞,扫描电子显微镜显示完整的细胞外基质,DNA 数量逐渐减少。使用不同的技术来证明 INTO 组织库生产的同种异体骨的质量,并建立确保这些产品安全性和质量的生物学参数。未来需要进行研究,以评估和验证更大的具有不同建筑结构的同种异体骨脱细胞过程的有效性。